Xiaoting Zhang

Title: Innovations in Cancer Treatment by Xiaoting Zhang

Introduction

Xiaoting Zhang is an accomplished inventor based in Cincinnati, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of multifunctional RNA nanoparticles. His work focuses on addressing therapeutic-resistant cancers, particularly tamoxifen-resistant breast cancer.

Latest Patents

Xiaoting Zhang holds 1 patent for his invention titled "Multifunctional RNA nanoparticles and methods for treating cancer and therapeutic resistant cancer." This patent describes RNA nanoparticles that are functionalized with a HER2-targeting RNA aptamer and at least one MED1 siRNA. These nanoparticles are designed for targeted delivery of MED1 siRNA to human cancer cells via human epidermal growth factor receptor 2 (HER2) receptors. The pharmaceutical compositions derived from this invention aim to treat breast cancers that are implicated with HER2, especially those that are resistant to conventional therapies.

Career Highlights

Throughout his career, Xiaoting Zhang has worked with notable institutions such as the University of Cincinnati and the Ohio State Innovation Foundation. His research has been pivotal in advancing the understanding and treatment of cancer, particularly in developing targeted therapies that improve patient outcomes.

Collaborations

Xiaoting Zhang has collaborated with Peixuan Guo, a prominent figure in the field. Their partnership has contributed to the advancement of innovative solutions in cancer treatment.

Conclusion

Xiaoting Zhang's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaborations continue to pave the way for new therapeutic strategies.